Briefly, sections were incubated in 1% cresyl violet solution (OKA, cat# 71041284) at 37 C for 30 min, followed by differentiation in graded ethanol solutions
Reported side effects Nausea (dose-dependent, more common at higher doses) Facial flushing and increased skin warmth Reduced appetite and mild fatigue Spontaneous erections or increased libido in men Injection site reactions (redness, mild stinging) Changes in existing moles Transient increases in heart rate and blood pressure Storage Lyophilised (unmixed) Freeze at -20 C (-4 F) or below, in dry, dark conditions
Some peptides, like BPC-157 and TB-500, are not approved drugs and have not been through FDA drug review
This is not a bug in retatrutide
Freezing causes crystallization within the medication, rendering it ineffective or potentially unsafe for injection
Your health care professional will provide medical advice on Semaglutide administration and additional information based on your medical history